United States · FDA National Drug Code directory
METAVEX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85477-503_0733c82d-8d75-4f70-9744-71e526509b95
- Product NDC
- 85477-503
- Form
- TABLET
- Composition / generic term
- METAVEX
- Labeler
- Oncora Pharma, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20260101
- Source listing expiry
- 20271231
Source-listed ingredients
- CHOLECALCIFEROL — .125 mg/1
- FOLIC ACID — 1 mg/1
- BLUE AGAVE INULIN (AGAVE TEQUILANA) — 500 mg/1
- ELM — 425 mg/1
- ALOE FEROX LEAF — 225 mg/1
- RHAMNUS CATHARTICA BARK — 135 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TABLET in 1 BOTTLE (85477-503-30) · 85477-503-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →